Healthcare Companies Worldwide

Healthera is a rapidly growing health tech company. It is a healthcare platform that provides patients with medicines, services and products through the largest digital network of pharmacies in the U.K. We work with over 1,500 pharmacies with a reach of over 30 million patients, including national chains and local branches. We provide patients with transparency on personal medication management and access to the fastest medicine delivery available.

We believe that everyone affected by hearing loss should have access to care. For this to happen, diagnosing hearing loss needs to be made easy and reliable. Our mission is to achieve this by developing an innovative new screening device.

Heart Force is about to break new ground in the early detection of heart disease. Through the assessment of the cardiac performance with a new unique technology we are able to detect coronary artery diseases at an early stage. Our Cardiac Performance Metrics represent a new capability for analyzing cardiac timing, rhythm and strength not found in the personal monitoring and screening space. Cardiovascular disease (CVD) is the number one cause of death globally (Source: WHO). Early detection is the missing key to successfully combat CVD, but difficult to achieve; CVD often does not show any symptoms. Through Heart Force it will be possible to self monitor the overall heart health and spend a life with more clarity concerning the overall heart health.

In Ovo combines animal welfare and efficiency by offering biotechnological solutions to the poultry industry. We currently focus on a long existing problem in hatcheries: The culling of one day old male chickens. Our solution, a gender screening in the first half of the breeding process, has several advantages. It prevents a lot of stress the chickens experience during the current manual gender sorting process, it reduces the energy consumption and CO2 emission of the hatchery and prevents the need to kill one day old chickens. This way, we make hatcheries more animal friendly and sustainable, and increase the efficiency at the same time.

Incision is a fast-growing platform for improving surgical performance and online training — with the mission to connect surgical professionals to what they need and help them find their personal best. Our “digital assistant” — a mobile app, helps members of the surgical team to learn visually, prepare, and align with one another on their daily work. We believe in sharing surgical skills and making high-quality surgical knowledge available to everyone. That's why we created Incision — to enable continuous surgical improvement that leads to better outcomes for everyone. We partner with leading clinics, societies and hospitals around the world to deliver the most accurate and high-quality content and services. Our continued strategic focus on product leadership has been rewarded with accreditations and endorsements from renowned international institutes like the Royal College of Surgeons, ESSO, EHS-GREPA, ASGBI, LVO, and NVAM. We have a Shareholder Board with esteemed surgeons and medical entrepreneurs and a Medical Advisory Board with renowned international surgeons including Jaap Bonjer and David Farley. Every day, we’re searching for new ways to support the efforts of the surgical team and make their challenging work run more smoothly. It's our vision to be the digital assitant of surgical professionals worldwide and the technology that supports that effort. Our dream is to impact 100 million procedures each year in 2030, connecting 10.000 clinics and millions of surgical professionals to what they need.

InFlectis BioScience is a private clinical stage company aiming at targeting and modulating interactions between proteins involved in key human pathophysiological processes. The company is developing small molecule drugs that specifically target the Integrated Stress Response (ISR). Exploiting the ISR’s natural defense offers tremendous potential for the development of a new class of therapies. Led by InFlectis, this area of research is rapidly advancing, resulting in new treatments under development for a variety of disease affecting the central nervous system (CNS), peripheral nervous system (PNS) and inflammation.

𝐝𝐨𝐜𝐭𝐨𝐫𝐚𝐧𝐲𝐭𝐢𝐦𝐞 is the #1 health tech multinational company to search for medical services. Founded in 2012 we are already operating in 6 countries. ▪️ We are an innovative platform that improves all functional/management matters of healthcare, like finding the right doctor for a user, booking appointments, creating and keeping a medical file etc. ▪️ Everyday we help hundreds of people to find the right doctor, the medical examination they need and book an online appointment with the selected doctor immediately. Setting as our main objective to respond to one simple need: 𝐭𝐨 𝐜𝐮𝐫𝐞 𝐚𝐧𝐝 𝐜𝐚𝐫𝐞, to offer anyone the security and peace of mind, when it comes to health related issues. ▪️ 𝐝𝐨𝐜𝐭𝐨𝐫𝐚𝐧𝐲𝐭𝐢𝐦𝐞 is free for patients and available in: - Greece - Belgium - Cyprus - Mexico - Argentina - Brazil - Peru - Ecuador - Colombia with many more soon to come.

At doctorly we are creating the future of digital health care. Our vision: 'Enabling people to live healthier lives'. We believe that technology, hand in hand with medical professionals, can create a truly modern and exponentially more effective approach to health care. With our unique b2b2c model, doctorly provides all of the digital technology, tools, and support, via a single system, for a doctor to efficiently and digitally manage their practice, and to engage with their patients like never before. We are also enabling patients to access, control and understand their own health records and data. Backed by some of the best investors in the world, the doctorly team is a wonderful mix of serial tech-entrepreneurs, amazing engineers & medical experts. We're hiring: https://doctorlycareer.kenjo.io/

Our mission is to create a comprehensive, patient-centric ecosystem that empowers individuals and healthcare professionals alike through a unique digital health platform to bring more quality of life for everyone.

BDD Pharma combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority submission, through to close out and production of ICH GCP-compliant clinical study report. We specialise in gamma scintigraphy, a powerful and versatile technology used to investigate the in vivo behaviour of your formulation. Coupled with pharmacokinetic data, this technique can be used to provide information on time /site of disintegration, gastric emptying, GI transit and intra/ inter individual differences.

Dudyfit is now HARBIZ ❤️‍🔥 We've evolved to remain the #1 app for fitness & wellness professionals. We're a client and service management platform for professionals - more than 4000 already! We help these professionals to digitize their businesses by increasing engagement, and revenue and making them scalable. We do this by unifying all the functionalities of the tools they currently use, i.e., WhatsApp, email, word, excel, bank transfers, skype, pen, and paper... All of this is integrated into a single platform minimizing the time spent on these management tasks, and providing traceability and analytics of all data collected from each client, thus professionalizing their services and their way of working.

Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes. The company has pioneered the early detection and identification of cancer employing infrared spectroscopy of circulating pan-omic biomarkers. The company has generated compelling clinical data with high accuracy detection of Stage I and Stage II cancers. Dxcover is based in Scotland, United Kingdom and is establishing operations in the USA.

Susu's mission is to make healthcare affordable and accessible for Africans, in an integrated approach which connects the beneficiaries of the services, their families, and healthcare professionals. - Our services include care bundles which are packages of curative and preventative services designed to monitor the condition of chronic disease patients and pregnant women. - We also offer insurance services in partnership with insurance providers. - Our offers can be subscribed by African diaspora members on behalf of their loved ones back home

Ada is a global health company created by doctors to improve human health by transforming knowledge into better outcomes. Ada is the world's most popular symptom assessment app, with 10 million users and 25 million completed assessments. Every three seconds, someone turns to Ada for personal health guidance. Our powerful enterprise solutions help partners inform health decisions, triage to appropriate care, and reduce avoidable costs. We work with healthcare systems and providers, insurers, payers and commissioners, life sciences, employers, governments, and non-profits.

Biorelate helps scientists solving the most difficult biomedical challenges of today. We do this by curating truths from existing knowledge, enabling smarter and faster research & development.

bit.bio is an award-winning human synthetic biology enterprise. Our mission is coding cells for health. To do so, we apply the principles of computation to biology. Our current focus is to develop a scalable technology platform capable of producing consistent batches of every human cell. This has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease. A scalable platform of consistent cells will also be the basis for a new generation of cell and tissue therapies. To achieve our goals, we have assembled a team of pioneers in stem cells, cellular reprogramming, mathematical modelling, and cell therapy. Collaboration is at the heart of bit.bio. We are empirical, highly ambitious and driven by a common purpose.

IOMED has developed a Natural Language Processing tool that allows hospitals to structure their information identifying clinically relevant variables from medical notes and structuring them into datasets, which can then be easily queried. Thanks to this data structuration, professionals and researchers from the hospitals can access to the information stored in their facilities more quickly thus accelerating patient recruitment by reducing the time invested in this process. At the same time, it allows hospitals to improve the quality of their services. Overall, we accelerate Clinical Research through the use of Artificial Intelligence, allowing access to structured RWD from hospital medical records and considerably optimizing your studies in time and access to patient volume. Finally, data protection is IOMED’s priority and we work to ensure a safe and secure environment: each hospital decides and authorizes all data uses and participation in projects, the data is stored entirely within the hospital, and always following international and Spanish legislation.

iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany. Backed by a powerful technology platform and internationally renowned investors, iOmx is driving forward a cutting-edge portfolio of early-stage novel immune-checkpoint drugs through pre-clinical and clinical development. Imprint: https://iomx.com/imprint

At Yoppie we’re building both digital and physical tools, services and products that enable today’s modern woman to take control of her menstrual health - starting with personalised eco friendly period care, PMS and condition supplements as well as hormonal skincare. We ultimately envision a world where women feel confident and empowered by their own unique menstrual cycle thanks to the removal of taboos, improved education and access to powerful subscription management tools. Check out our Full Stop Blog for answers to some of the most common menstrual health questions www.yoppie.com/blog

Cake (joincake.com) provides a digital platform that makes it easier to do advance care planning and end-of-life planning. Cake is one of Built In Boston’s “50 Tech Startups to Watch in 2018” and has been featured in The New York Times, BBC, Forbes, The Huffington Post, and The Boston Globe. MISSION: Together, we are building a destination for end-of-life planning, response, and inspiration. Reflecting on what we would want at end of life helps us to live congruently with our values, be considerate of our loved ones, and bring new meaning to living. Check out our job postings on Angellist: https://angel.co/joincake/jobs/

Jutro Medical’s advanced telemedicine platform and app offer virtual consultations, prescriptions, referrals, lab results and the ability to request medical leave online for less complex cases. Yet when more direct, more detailed or more complex care is required, patients can be seen by a Jutro Medical practitioner – typically the practitioner they’ve been liaising with virtually to maintain a continuity of care – at the startup’s proprietary clinics. All on the same day and all without waiting times, or having to constantly repeat their medical history and care needs with various people. This improves the experience for patients, gets them access to the best care possible, all while making doctors more productive.

Make Team Culture your Competitive Advantage. Upskill your Team Leaders to build more human teams with The Culture Academy - action focussed, cohort-based learning programmes. Learn more at https://kaido.org.

We took telemedicine to a whole new level. Invented the first Precision Medicine platform. And didn't survive the Covid-19 crisis. Thank you. We'll miss you.

B-Secur is a heart health technology company. Founded in Belfast, Northern Ireland, we are on a mission to save and improve millions of lives each year by advancing heart health technology that brings greater clarity to EKG interpretation with better data and deeper insights. We spent many years immersed in deep scientific research in EKG biometric security. This led us on a unique journey to develop heart health technology and drive better health outcomes for future generations. Covid-19 has accelerated the pace of our innovation as the world of medical technology and consumer devices converge. We have created HeartKey® 2.0, a suite of powerful EKG algorithms and analytics that enhances signal clarity, reduces signal noise, and delivers FDA-cleared health data with actionable wellness insights. We partner with world-leading technology companies reducing time to market for next generation medical and consumer devices and platforms. Our expertise in EKG coupled with deep experience in hardware, software and science enables our partners to tackle the fundamental healthcare issues of today.

Axial3D, a leader in medical segmentation and 3D printing, provides hospitals and medical device manufacturers access to an easy to use, fast, affordable way to transform 2D medical image data into 3D. Through our 510(k) cleared, cloud-based segmentation platform, we convert patients’ DICOM data into accurate and data rich 3D visualizations, printable files, and 3D models printed with Stratasys print technology in an efficient and scalable way. Our mission is to make patient-specific 3D solutions accessible to all, enabling surgeons, radiologists, and engineers the resources to improve patient outcomes and accelerate patient specific programs.

Neuroelectrics® is a digital brain health company that innovates at the intersection of neuroscience, physics, machine learning, and hardware. We have developed wireless EEG and tDCS/tACS/tRNS stimulation devices with up to 32 channels, amongst other products encompassing software and research services, with the purpose of monitoring and enhancing brain health.

Nightingale Health is a health technology company transforming preventive care. We envisage a world that focuses on keeping people healthy rather than just treating illnesses. The wide-ranging disease risk predictions provided by Nightingale consist of two interconnected factors: The extensive blood analysis technology developed by Nightingale and a large amount of data on health events. Nightingale helps people make better personal health decisions and connects the health industry to offer their services for individuals' preventative needs. By empowering the world with comprehensive health insights, we accelerate scientific discoveries, industry developments and improve personal health for everyone. We’re a team of 60 members––a diverse bunch with interdisciplinary expertise in business, marketing, computational medicine, data science, healthcare, IT, design and more––who envisage a world that focuses on keeping people healthy rather than just treating illnesses. So, if you are looking to enable good tech that could make a real difference, Nightingale is the place to be.

Innovation to patient, faster Platomics enables in vitro diagnostic manufacturers and laboratories to bring safe and effective innovations to market with unparalleled speed and efficiency. Our global platform for generating and marketing compliant IVD products is equipped with intelligent regulatory automation that allows our clients to seamlessly overcome regulatory challenges over the entire life cycle of their products.

Innovative polish company offering monitoring wristbands and telemedine platform to hospitals, institutions, idividuals SiDLY initiates the development of medical telematics in Poland and Europe. SiDLY sp.z o.o. as one of the first organizations, deal comprehensively with medical diagnostics from the distance, starting from the search of areas requiring initiating telematics solutions through design, testing and constructing of both- devices and systems, and the dedicated application. SiDLY team, consists of the representatives of technology, medicine and science. The products of SiDLY improve the work of clinics and houses of Social Welfare. They also enable a remote medical diagnostics for individual costumers. Telemedical platform with wristbands is implemented in hospitals, including contagious departures.

Pharmacy2U is the UK's first and largest online pharmacy. We're a market leader in the pharmacy world, helping over 750,000 patients in England manage their NHS repeat prescriptions from request through to delivery. For over 20 years, we have used cutting-edge technology alongside our UK-based pharmacists, dispensing specialists, and customer care advisers to help improve the lives of patients. Our Leeds and Leicester -based dispensing facilities distribute over 1 million medication items to patients across England every month. KPMG’s Customer Excellence report recently revealed Pharmacy2U is the UK’s number one brand for experience and value, based on a survey of over 10,000 UK consumers. This accolade cements our position as the nation’s go-to online pharmacy and keeps us committed to further broadening our healthcare offering. Our goal is to make simple and convenient healthcare accessible to all. As well as our repeat prescriptions service, patients can also access: - A one-stop online healthcare shop featuring over 4,000 products - Confidential online GP consultations for a range of conditions - Enhanced pharmacy services such as the NHS New Medicine Service We're an ambitious company with big plans and we're looking for talented individuals to join our team and help us to continue excelling in our field. Our CEO Kevin Heath says, “come and join a team that truly lives by our company values of putting the patient at the heart of everything we do”. Want to help shape the future of online healthcare in the UK? Discover our latest vacancies today.

Oncomfort Digital Sedation™ is a non-pharmacological therapy for relieving patients’ pain and anxiety before, during and after medical procedures. This digital therapy combines clinical hypnosis and integrative therapeutic techniques through Virtual Reality.

We are Germany's first purely digital health insurance company. Our mission is to finally make the complex topic of health insurance and healthcare simple and transparent. As a reliable healthcare partner, we help people stay healthy or become healthy. 100 % digital, 100 % human. In addition to private comprehensive health insurance and supplementary health insurance, ottonova's portfolio also includes software solutions for the insurance industry. Digital also means that we are, of course, personally available to our customers for questions and concerns, always just a click away. In this way, we want to give them more time for the life they want to live. That's why we are constantly developing our digital services. In 2022, ottonova was named the insurer with the highest customer satisfaction for the fourth time in a row in the KUBUS study of private health insurers. Our employees think: there are many reasons to work for us. They have voted us one of the best employers in Germany. Because our ottonova spirit makes us a "Great Place to Work: We work as a team, across locations, disciplines and career levels, and together we boldly break new ground and provide the necessary freedom for new impulses to make healthcare as innovative and effective as possible. ottonova has also been certified as a climate-neutral company since 2022. We are proud of that!

Liva Healthcare is Europe’s leading provider of scalable digital health coaching. Through an app Liva is providing personal human coaching programmes to help people manage obesity, pre-diabetes, type 2 diabetes and cardiovascular diseases. Liva is headquartered in Copenhagen with offices in London and Berlin, and the company's multi-award winning platform is now operational in nine countries across Europe and the South-Pacific. The company was founded in 2015 by the founders behind Europe’s leading independent health information portal, NetDoctor.com, Rune Bech and Carl Brandt, together with Kristoffer From. In 2017, Liva was selected by NHS England among 84 providers as a digital provider to their world-leading National Diabetes Prevention Programme (NDPP). Among Liva’s other major clients are insurance giants like AXA and Bupa, and pharmaceutical companies like Amgen and Novo Nordisk, and public and private healthcare providers across Europe. Through Liva’s app, users have access to a real human health coach, designing a personalised lifestyle change programme for them based on their individual needs. After a live video kick-off the participant then receives continuous professional guidance, support, motivation, and empathy via Liva's app. The goal is to help them prevent, manage or reverse chronic conditions through a new sustainable healthy lifestyle and behaviour changes. Participants can track their progress real-time via the app and engage with a support group of peers to keep them motivated. In several studies, Liva has been proven to drive substantial clinical outcomes, also in socio-economic backgrounds normally hard to reach. Liva is funded by VerlInvest, MIG, Digital Health Ventures, Santo Venture Capital, and Maj Invest. For more information visit livahealthcare.com

Alan is your one stop health partner. We give everyone access to a healthy & productive life, empowering the body and the mind. Our services include the most intuitive health insurance offering, our Alan Clinic to navigate the healthcare system and Alan Mind, our mental well-being offer among other things! We cover more than 315.000 members and are partners of 20.000 companies for the health of their employees. With Alan, people are healthier, happier and more productive. We are the first new independent insurance licensed in France since 1986 by the French Prudential Supervisory Authority (ACPR). We operate in 🇫🇷, 🇧🇪 and 🇪🇸. Alan has raised more than €490 million.

Byteflies is a med tech company that provides B2B-services to enable lean development of wearable health applications. With a proprietary platform to set up wearable health solutions instantly, Byteflies works with pharmaceutical companies that are embracing clinical trial innovation and the value-based healthcare model; researchers looking for cutting edge technology to monitor patients; and tech companies wanting to quickly push new wearable technology to the market. Our team consists of world experts in the field of wearable health and the development of digital biomarkers.

Founded in 2016 and headquartered in Amsterdam, Siilo is a secure and GDPR compliant medical messaging app designed to help healthcare professionals and teams better collaborate on complex cases, improve patient care, and share knowledge in a compliant way. Today, Siilo is the largest medical network in Europe, with over a quarter-million active users who, to date, have exchanged over 1 billion messages. While the Siilo Messenger app is free for individual users to download, Siilo also partners with medical associations like AGIK and KAVA, and hospitals like Charité, UMC Utrecht, and Erasmus MC to deliver organisational and departmental collaboration.

Abionic, an in vitro diagnostics (IVD) company, was founded in 2010 as a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL). Abionic is aiming to make a difference in patient care through the cutting-edge nanofluidic technology based ultra-rapid diagnostic platform, helping healthcare professionals to make clinical decisions at the point of care.

A new medicine R&D engine (R&D pharma company) operated by an experienced team dedicated to the discovery and development of new medicines to treat patient suffering from severe diseases of the central nervous system. Accure Therapeutics focuses on neurons that suffer a dysfunction, and on the glial environment that supports them, in an attempt to impede their degeneration and death. We work to find new medicines that correct the pathological changes that are responsible for the disease, and that produce beneficial outcomes (i.e. Disease Modifying Therapies). We specialize in developing drugs that promote neuroprotection and neurorepair by integrating the latest advances in neurobiology with state-of-the-art clinical research. We have currently built up a drug candidate portfolio that focuses on four areas: Optic Neuritis, Multiple Sclerosis, Parkinson’s Disease and Epilepsy.

AceCann is a Portuguese medical cannabis company that has put together a strong management team with diversified and complementary backgrounds that we trust will make a difference in the global market. The team combines +60 years of healthcare/pharma experience, +11 years operating medical cannabis companies in Canada and Portugal, and +14 years operating with technology/data business. AceCann’s scope of action is: •Organic Medical Cannabis Cultivation & Extraction Facility - building a cost-efficient, scalable and superior quality organic indoor cultivation and extraction facility near Lisbon leveraging on the experience from one or our shareholders •Therapeutics Research & Development - focused on the development of new medical delivery forms for cannabis, joining efforts with local and international universities With a team accustomed to highly volatile environments, AceCann is setting up a flexible structure to learn from a market in constant evolution & change, capable of making fast decisions to scale according to market demands & needs

Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services aim to escalate the efficiency and precision of medical image analysis, across a variety of fields from oncology to neuroscience and more. From empowering researchers in the identification of novel biomarkers of disease, and supporting R&D scientists in speeding up time-to-market of novel drugs, to helping pathologists enhance the accuracy of cancer diagnostics — Aiforia has the expertise and experience to transform healthcare all the way from discovery to diagnosis.

Aktiia – Bringing blood pressure monitoring to daily life Aktiia was founded in 2018 to commercialize its proprietary cuffless optical Blood Pressure Monitoring technology (oBPM™) in order to contribute to the prevention of high blood pressure, to save lives and to help reduce healthcare costs worldwide. aktiia is headquartered in Neuchatel (Switzerland) with offices opening up in Zurich (Switzerland) and the USA.

ALEVA is 👉THE COMPANY THAT INTRODUCED Directional Deep Brain Stimulation in Neuromodulation treatments and our clinically proven technology has set the industry standard for directional leads* Today we are 👉A SOLID COMPANY that following directSTIM™'s CE marking have started our commercial journey by partnering with the most important neurological clinics in Germany, with the goal to soon reach the most relevant European markets. We understand that if we want to help OUR CUSTOMERS, overcome their challenges, we need to 👉COMBINE SPECIALISATION with the 👉COMMITMENT TO BE RESPONSIVE to the everyday new challenges they experience. This is the attitude you will find in every ALEVA employee and sales representative who will be in contact with you. We are the 👉ONLY EUROPEAN COMPANY that designs, manufactures, and commercialises DBS devices for the treatment of Parkinson’s disease and essential tremor. Our production and R&D headquarters based in Switzerland complies to the highest quality standard for the highest safety of patients worldwide. Our A VISIONARY PROJECT SUSTAINED BY SOLID FOUNDATIONS: 👉a new group of investors that will sustain the completion of OUR PROJECT 👉a reinforced executive team who is complementing the existing successful group to partner with Neurosurgeons and Neurologists in the effective deployment of our Vision. *May 28, 2014 http://doi.org/10.1093/brain/awu102.

At Alex Therapeutics, we design and develop CE-certified Digital Therapeutics (DTx) products. We’re a pioneer within our field, combining Cognitive Behavioural Therapy (CBT) and Acceptance and Commitment Therapy (ACT) with Artificial Intelligence to provide patients with highly personalized and effective care. The Alex Platform allows for the easy development of new products, and we see incredible potential in future verticals such as obesity, depression, oncology, and more. We’re always looking for great partners and co-workers. Please send us an email at partner@alextherapeutics.com to get in touch.

Alkermes focuses on the development of innovative medicines that seek to address unmet needs of people living with serious mental illness, addiction, and cancer. As a fully-integrated, global biopharmaceutical company, we apply our scientific expertise and proprietary technologies to develop products that are designed to make a meaningful difference in the way patients manage their disease. We are inspired by some of the most pressing public health challenges of our time to help advance innovation with the potential to improve treatment options and outcomes for patients. Beyond our important mission of developing medicines, we believe it is our responsibility to take a holistic approach as we seek to support patients, caregivers, and broader impacted communities. In this context we also work to help support and enhance the systems through which these complex diseases are treated. We are committed to patient engagement, disease education and awareness, and advocacy for important policies that support equitable access to quality treatment. Headquartered in Dublin, Ireland, we have an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. See our Community Guidelines: https://www.alkermes.com/social-community-guidelines

AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. The mission of the company is extending people's lives, developing disruptive technologies to detect the tumor years in advance, before the symptoms appear.

"Amelia Virtual Care - formerly known as Psious - is an easy-to-use, fast and affordable virtual reality tool for mental health professionals. Founded in 2014, based in Mountain View, CA and Barcelona, Amelia supports psychologists and mental health professionals around the world who perform mental health assessments and interventions. It provides professionals with tools that can help them individualize and simplify processes for each and every individual.

Health is the level of functional or metabolic efficiency of a living organism. In humans it is the ability of individuals or communities to adapt and self-manage when facing physical, mental or social challenges.

We’re a company that offers accessible health plans which include services and insurance coverage against day-to-day ailments, common illnesses, and medical emergencies. We are a Madrid-based insurtech, with operations in Latin America and South East Asia, focused on supporting those who have migrated, so they can continue caring for their loved ones back home, from anywhere. Our vision is to make healthcare accessible to everyone using the power of technology Our mission is to empower migrants to live their lives abroad with the peace of mind that we take care of their loved ones’ health back home. Want to join our team? Visit our career page here: https://asistensi.teamtailor.com/

Who we are: atai is a biopharmaceutical company that leverages a decentralised platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients. Our vision: To heal mental health disorders so that everyone, everywhere can live a more fulfilled life. Our approach: By pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.

BC Platforms is a global leader in building data networks for the life sciences industry and provides versatile technology platforms for personalised medicine, accelerating the translation of innovations into clinical practice. We convert complex biological information collected in the healthcare setting into actionable insights. With our innovative technology we are creating a patient centric infinity loop between the life sciences and healthcare sectors. Data we generate, harmonise, and manage, from diverse biobanks and healthcare institutions, is made accessible for pharmaceutical and biotech companies to enhance their core strengths in research and development. In parallel, we enable stratification of patients towards targeted therapies, delivering on the promise of more personalized healthcare. Our high performing genomic data discovery and analytics platform enables flexible data integration, secure analysis, and interpretation of molecular and clinical information. We have developed a Global Data Partner Network, BCRQUEST.com, which allows access to high-quality real-world data. This rapidly growing network has a footprint across many sites, including networks of major hospitals, covering 20 countries in five continents, providing standard of care data for over 23 million patients. Our platforms seamlessly facilitate access to highly enriched data for pharmaceutical research and development. Founded in 1997 from a MIT Whitehead project spinoff, we have a strong scientific heritage underpinned by over 25 years of working in close collaboration with a network of leading researchers, developers, and industry partners. We have global operations with our headquarters in Zurich, Switzerland, R&D in Espoo, Finland, and Singapore, as well as a presence in London and Boston. For more information, please visit www.bcplatforms.com.